TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reducing Sedentary Behavior to Decrease Low Back Pain: Stand Back Study
Brief Summary: This study will test the effects of a sedentary behavior intervention on low back pain in working adults. The behavioral intervention will include the use of a sit-stand desk and a wrist-worn activity prompter that will notify participants when they have been sedentary for too long.


Options:
A: Arm Label: Sitting time Change Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Sitting time Change Intervention | Arm Label: Active Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Sitting time Change Intervention; Assigned to Arm(s): Sitting time Change Intervention
B: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intervention | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: No intervention | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Control
C: Arm Label: Physical Activity Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Intervention | Arm Label: Wellness Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Wellness Control | Intervention Type: BEHAVIORAL; Name: Physical Activity Intervention; Assigned to Arm(s): Physical Activity Intervention | Intervention Type: BEHAVIORAL; Name: Wellness Control; Assigned to Arm(s): Wellness Control
D: Arm Label: Physical activity treatment group; Type: EXPERIMENTAL; Interventions: Behavioral: Pedal@Work | Arm Label: Wait List Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Pedal@Work Worksite Wellness | Intervention Type: BEHAVIORAL; Name: Pedal@Work Worksite Wellness; Assigned to Arm(s): Wait List Control | Intervention Type: BEHAVIORAL; Name: Pedal@Work; Assigned to Arm(s): Physical activity treatment group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reducing Sedentary Behavior to Decrease Low Back Pain: Stand Back Study
Brief Summary: This study will test the effects of a sedentary behavior intervention on low back pain in working adults. The behavioral intervention will include the use of a sit-stand desk and a wrist-worn activity prompter that will notify participants when they have been sedentary for too long.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Sit-stand workstation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-stand workstation; Assigned to Arm(s): Intervention
B: Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: Active Workstation Intervention, Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Arm Label: Active Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ergonomic Intervention, Behavioral: Email Intervention, Device: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application. | Intervention Type: BEHAVIORAL; Name: Active Workstation Intervention; Assigned to Arm(s): Experimental Group | Intervention Type: BEHAVIORAL; Name: Ergonomic Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: BEHAVIORAL; Name: Email Intervention; Assigned to Arm(s): Active Control, Experimental Group | Intervention Type: DEVICE; Name: Bluetooth enabled device (Wahoo Fitness Blue SC sensor) and accompanying iPod application.; Assigned to Arm(s): Active Control, Experimental Group
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention group | Arm Label: Intervention control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control group | Intervention Type: BEHAVIORAL; Name: Intervention group; Assigned to Arm(s): Intervention group | Intervention Type: BEHAVIORAL; Name: Control group; Assigned to Arm(s): Intervention control
D: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intervention | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: No intervention | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in Their Infants
Brief Summary: The purpose of this study is to determine the efficacy of maternal immunization with the RSV F vaccine against symptomatic RSV lower respiratory tract infection (LRTI) with hypoxemia through the first 90 days of life in infants.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: MEDI8897 50 mg; Type: EXPERIMENTAL; Interventions: Drug: MEDI8897 | Intervention Type: DRUG; Name: MEDI8897; Assigned to Arm(s): MEDI8897 50 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Treated; Type: N/A; Interventions: N/A | Arm Label: Untreated; Type: N/A; Interventions: N/A
C: Arm Label: Treatment Group A; Type: PLACEBO_COMPARATOR; Interventions: Biological: Formulation buffer | Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: RSV F vaccine with adjuvant | Intervention Type: BIOLOGICAL; Name: RSV F vaccine with adjuvant; Assigned to Arm(s): Treatment Group | Intervention Type: BIOLOGICAL; Name: Formulation buffer; Assigned to Arm(s): Treatment Group A
D: Arm Label: Palivizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Palivizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Palivizumab; Assigned to Arm(s): Palivizumab | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in Their Infants
Brief Summary: The purpose of this study is to determine the efficacy of maternal immunization with the RSV F vaccine against symptomatic RSV lower respiratory tract infection (LRTI) with hypoxemia through the first 90 days of life in infants.


Options:
A: Arm Label: Treatment Group A; Type: PLACEBO_COMPARATOR; Interventions: Biological: Formulation buffer | Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: RSV F vaccine with adjuvant | Intervention Type: BIOLOGICAL; Name: RSV F vaccine with adjuvant; Assigned to Arm(s): Treatment Group | Intervention Type: BIOLOGICAL; Name: Formulation buffer; Assigned to Arm(s): Treatment Group A
B: Arm Label: Placebo + Inactivated Influenza Vaccine (IIV); Type: ACTIVE_COMPARATOR; Interventions: Biological: IIV, Other: Placebo | Arm Label: MEDI7510 + IIV; Type: EXPERIMENTAL; Interventions: Biological: MEDI7510, Biological: IIV | Intervention Type: BIOLOGICAL; Name: MEDI7510; Assigned to Arm(s): MEDI7510 + IIV | Intervention Type: BIOLOGICAL; Name: IIV; Assigned to Arm(s): MEDI7510 + IIV, Placebo + Inactivated Influenza Vaccine (IIV) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo + Inactivated Influenza Vaccine (IIV)
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: MEDI-534 | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Biological: MEDI-534 | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Biological: MEDI-534 | Intervention Type: BIOLOGICAL; Name: MEDI-534; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: MEDI-534; Assigned to Arm(s): 2 | Intervention Type: BIOLOGICAL; Name: MEDI-534; Assigned to Arm(s): 3
D: Arm Label: Group 1: Ad26.RSV.preF; Type: EXPERIMENTAL; Interventions: Biological: Ad26.RSV.preF | Arm Label: Group 2: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: Ad26.RSV.preF; Assigned to Arm(s): Group 1: Ad26.RSV.preF | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 2: Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Open-label, Multicenter Trial of Avelumab (MSB0010718C) as a Third-line Treatment of Unresectable, Recurrent, or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Brief Summary: The purpose of this study was to demonstrate superiority of treatment with avelumab plus best supportive care (BSC) versus physician's choice (chosen from a pre-specified list of therapeutic options) plus BSC.


Options:
A: Arm Label: Ramucirumab (IMC-1211B) Drug Product (DP) and Paclitaxel; Type: EXPERIMENTAL; Interventions: Biological: Ramucirumab (IMC-1211B) DP, Drug: Paclitaxel | Arm Label: Placebo and Paclitaxel; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Paclitaxel | Intervention Type: BIOLOGICAL; Name: Ramucirumab (IMC-1211B) DP; Assigned to Arm(s): Ramucirumab (IMC-1211B) Drug Product (DP) and Paclitaxel | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo and Paclitaxel | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Placebo and Paclitaxel, Ramucirumab (IMC-1211B) Drug Product (DP) and Paclitaxel
B: Arm Label: Pembrolizumab; Type: EXPERIMENTAL; Interventions: Biological: pembrolizumab | Arm Label: Chemotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: paclitaxel, Drug: docetaxel, Drug: irinotecan | Intervention Type: BIOLOGICAL; Name: pembrolizumab; Assigned to Arm(s): Pembrolizumab | Intervention Type: DRUG; Name: paclitaxel; Assigned to Arm(s): Chemotherapy | Intervention Type: DRUG; Name: docetaxel; Assigned to Arm(s): Chemotherapy | Intervention Type: DRUG; Name: irinotecan; Assigned to Arm(s): Chemotherapy
C: Arm Label: Physician choice chemotherapy+Best Supportive Care (BSC); Type: EXPERIMENTAL; Interventions: Drug: Irinotecan, Drug: Paclitaxel, Other: Best Supportive Care (BSC) | Arm Label: Avelumab+BSC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Avelumab, Other: Best Supportive Care (BSC) | Intervention Type: DRUG; Name: Avelumab; Assigned to Arm(s): Avelumab+BSC | Intervention Type: DRUG; Name: Irinotecan; Assigned to Arm(s): Physician choice chemotherapy+Best Supportive Care (BSC) | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Physician choice chemotherapy+Best Supportive Care (BSC) | Intervention Type: OTHER; Name: Best Supportive Care (BSC); Assigned to Arm(s): Avelumab+BSC, Physician choice chemotherapy+Best Supportive Care (BSC)
D: Arm Label: TAS-102+BSC; Type: EXPERIMENTAL; Interventions: Drug: TAS-102 | Arm Label: Placebo+BSC; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: TAS-102; Assigned to Arm(s): TAS-102+BSC | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo+BSC

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison Between Intradermic vs Habitual Skin Closure Technique in Open Appendicectomy.
Brief Summary: To compare the results associated with two different skin closure techniques in open appendectomy. 200 patients were included after acute appendicitis diagnosis in emergency department. They were grouped randomly into two groups: patients who would receive skin closure with skin closure by an unique absorbable intradermic stitch (Group A) and another that would receive a habitual technique consistent in non absorbable separated stitches (Group B). General characteristics like gender, age, body mass index (IMC), comorbidities and allergies were registered. Days of evolution (DOE) until surgery, use of antibiotics previously, complicated or uncomplicated appendicitis, surgery time and wound complications like skin infection, dehiscence, seroma or abscess were registered in each case too,


Options:
A: Intervention Type: DEVICE; Name: wound closure device (Steri-Strip™); Assigned to Arm(s): N/A
B: Arm Label: Staple Closure; Type: EXPERIMENTAL; Interventions: Procedure: Staple Closure | Arm Label: Running Subcuticular Closure; Type: EXPERIMENTAL; Interventions: Procedure: Running Subcuticular Closure | Arm Label: Vertical Mattress Closure; Type: EXPERIMENTAL; Interventions: Procedure: Vertical Mattress Closure | Intervention Type: PROCEDURE; Name: Staple Closure; Assigned to Arm(s): Staple Closure | Intervention Type: PROCEDURE; Name: Vertical Mattress Closure; Assigned to Arm(s): Vertical Mattress Closure | Intervention Type: PROCEDURE; Name: Running Subcuticular Closure; Assigned to Arm(s): Running Subcuticular Closure
C: Arm Label: Interrupted suturing Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Interrupted suturing | Arm Label: Subcuticular suturing Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Subcuticular suturing | Intervention Type: OTHER; Name: Interrupted suturing; Assigned to Arm(s): Interrupted suturing Group | Intervention Type: OTHER; Name: Subcuticular suturing; Assigned to Arm(s): Subcuticular suturing Group
D: Arm Label: Continuous intradermic stitch; Type: EXPERIMENTAL; Interventions: Procedure: Continuous intradermic stitch | Arm Label: Separated stitches; Type: SHAM_COMPARATOR; Interventions: Procedure: Separated stitches | Intervention Type: PROCEDURE; Name: Continuous intradermic stitch; Assigned to Arm(s): Continuous intradermic stitch | Intervention Type: PROCEDURE; Name: Separated stitches; Assigned to Arm(s): Separated stitches

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment of DHA On Reducing Early Preterm Birth (ADORE Trial)
Brief Summary: The purpose of this study is to determine if giving a larger amount of DHA than currently included in some prenatal supplements can reduce early preterm birth (birth before 34 weeks of pregnancy).


Options:
A: Arm Label: 200 mg/day DHA; Type: PLACEBO_COMPARATOR; Interventions: Drug: Docosahexaenoic acid - 200mg/day, Other: Placebo | Arm Label: 1000 mg/day DHA; Type: EXPERIMENTAL; Interventions: Drug: Docosahexaenoic acid - 800mg/day, Drug: Docosahexaenoic acid - 200mg/day | Intervention Type: DRUG; Name: Docosahexaenoic acid - 800mg/day; Assigned to Arm(s): 1000 mg/day DHA | Intervention Type: DRUG; Name: Docosahexaenoic acid - 200mg/day; Assigned to Arm(s): 1000 mg/day DHA, 200 mg/day DHA | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): 200 mg/day DHA
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: n-3 fatty acid | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: olive oil | Intervention Type: DIETARY_SUPPLEMENT; Name: n-3 fatty acid; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: olive oil; Assigned to Arm(s): 2
C: Arm Label: Lifestyle counseling + PUFA supplement; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle counseling, Dietary Supplement: PUFA Supplementation | Arm Label: Routine diet & PA + PUFA Supplementation; Type: EXPERIMENTAL; Interventions: Dietary Supplement: PUFA Supplementation, Behavioral: Routine diet & PA | Arm Label: Lifestyle counseling + PUFA placebo; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle counseling, Dietary Supplement: PUFA placebo | Arm Label: Routine diet & PA + PUFA placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Routine diet & PA, Dietary Supplement: PUFA placebo | Intervention Type: BEHAVIORAL; Name: Lifestyle counseling; Assigned to Arm(s): Lifestyle counseling + PUFA placebo, Lifestyle counseling + PUFA supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: PUFA Supplementation; Assigned to Arm(s): Lifestyle counseling + PUFA supplement, Routine diet & PA + PUFA Supplementation | Intervention Type: BEHAVIORAL; Name: Routine diet & PA; Assigned to Arm(s): Routine diet & PA + PUFA Supplementation, Routine diet & PA + PUFA placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: PUFA placebo; Assigned to Arm(s): Lifestyle counseling + PUFA placebo, Routine diet & PA + PUFA placebo
D: Arm Label: DHA capsules; Type: EXPERIMENTAL; Interventions: Drug: DHA | Arm Label: Placebo capsules; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo capsule | Intervention Type: DRUG; Name: DHA; Assigned to Arm(s): DHA capsules | Intervention Type: OTHER; Name: Placebo capsule; Assigned to Arm(s): Placebo capsules

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Motivation Matters! Randomized Clinical Trial of Theory Based SMS to Support Treatment as Prevention in High-Risk Women
Brief Summary: The study aims to develop and evaluate the efficacy and causal mechanisms of an interactive SMS intervention to optimize individual health and secondary HIV prevention benefits of ART in HIV-positive FSWs.


Options:
A: Arm Label: Positive adjustment coping intervention; Type: EXPERIMENTAL; Interventions: Other: Positive adjustment coping intervention | Arm Label: Brainteaser; Type: OTHER; Interventions: Other: Brainteaser | Intervention Type: OTHER; Name: Positive adjustment coping intervention; Assigned to Arm(s): Positive adjustment coping intervention | Intervention Type: OTHER; Name: Brainteaser; Assigned to Arm(s): Brainteaser
B: Arm Label: Cell-phone assisted; Type: EXPERIMENTAL; Interventions: Device: Cell-phone | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cell-phone; Assigned to Arm(s): Cell-phone assisted
C: Arm Label: Individualized, interactive SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Individualized, interactive short messaging intervention | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Individualized, interactive short messaging intervention; Assigned to Arm(s): Individualized, interactive SMS
D: Arm Label: Smartphone-enabled app for linkage to care; Type: EXPERIMENTAL; Interventions: Other: Smartphone application, Device: Smartphone | Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Smartphone application; Assigned to Arm(s): Smartphone-enabled app for linkage to care | Intervention Type: DEVICE; Name: Smartphone; Assigned to Arm(s): Smartphone-enabled app for linkage to care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Motivation Matters! Randomized Clinical Trial of Theory Based SMS to Support Treatment as Prevention in High-Risk Women
Brief Summary: The study aims to develop and evaluate the efficacy and causal mechanisms of an interactive SMS intervention to optimize individual health and secondary HIV prevention benefits of ART in HIV-positive FSWs.


Options:
A: Arm Label: Individualized, interactive SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Individualized, interactive short messaging intervention | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Individualized, interactive short messaging intervention; Assigned to Arm(s): Individualized, interactive SMS
B: Arm Label: mHealth; Type: EXPERIMENTAL; Interventions: Other: mHealth | Arm Label: No mHealth; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: mHealth; Assigned to Arm(s): mHealth
C: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: promotional Exclusive breastfeeding text messages | Arm Label: control; Type: OTHER; Interventions: Other: promotional Exclusive breastfeeding text messages | Intervention Type: OTHER; Name: promotional Exclusive breastfeeding text messages; Assigned to Arm(s): control, intervention
D: Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Behavioral: Counseling | Arm Label: Automated Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Other: Smartphone-delivered automated treatment | Intervention Type: BEHAVIORAL; Name: Self-help materials; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: BEHAVIORAL; Name: Counseling; Assigned to Arm(s): Standard Treatment | Intervention Type: OTHER; Name: Smartphone-delivered automated treatment; Assigned to Arm(s): Automated Treatment

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Motivation Matters! Randomized Clinical Trial of Theory Based SMS to Support Treatment as Prevention in High-Risk Women
Brief Summary: The study aims to develop and evaluate the efficacy and causal mechanisms of an interactive SMS intervention to optimize individual health and secondary HIV prevention benefits of ART in HIV-positive FSWs.


Options:
A: Arm Label: Philani Intervention Model+MOVIE (PIM+M); Type: EXPERIMENTAL; Interventions: Behavioral: Philani Intervention Model+MOVIE (PIM+M) | Arm Label: Philani Intervention Model (PIM); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Philani Intervention Model (PIM) | Intervention Type: BEHAVIORAL; Name: Philani Intervention Model+MOVIE (PIM+M); Assigned to Arm(s): Philani Intervention Model+MOVIE (PIM+M) | Intervention Type: BEHAVIORAL; Name: Philani Intervention Model (PIM); Assigned to Arm(s): Philani Intervention Model (PIM)
B: Arm Label: Text message vaccine reminders; Type: EXPERIMENTAL; Interventions: Other: Text Message, Other: automated call | Arm Label: automated phone call from clinic; Type: ACTIVE_COMPARATOR; Interventions: Other: automated call | Intervention Type: OTHER; Name: Text Message; Assigned to Arm(s): Text message vaccine reminders | Intervention Type: OTHER; Name: automated call; Assigned to Arm(s): Text message vaccine reminders, automated phone call from clinic
C: Arm Label: Individualized, interactive SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Individualized, interactive short messaging intervention | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Individualized, interactive short messaging intervention; Assigned to Arm(s): Individualized, interactive SMS
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Reminders; Type: EXPERIMENTAL; Interventions: Behavioral: Reminders | Intervention Type: BEHAVIORAL; Name: Reminders; Assigned to Arm(s): Reminders

Answer: C